GFOR
Graf Acquisition Corp. IV
A special purpose acquisition company (SPAC), a type of "blank-check" firm that raises money in order to take a private business public. Founded in 2021 by serial SPAC founder James Graf and based in The Woodlands, Texas, it went public that year and merged with NKGen Biotech, a clinical-stage biotech developing natural killer cell therapies. When the deal closed in October 2023, the company took the name NKGen Biotech and began trading on the Nasdaq.
SPACUnderlying: GFORCUSIP: 384272100FinancialsUS1 holder
Common stock of Graf Acquisition Corp. IV, a SPAC that completed business combination with NKGen Biotech — Merged with NKGen Biotech in September 2023
Total Value
$995.0K
Total Shares
100.0K
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
